12 Things You Should NEVER Mix with Ozempic or Mounjaro

Drug Interactions and Lifestyle Conflicts Most Patients Never Consider

Dr. G from the Lifestyle Medicine Network is back with another list-format video, and this one has legs. Over 425,000 views for a video about things to avoid while taking Ozempic or Mounjaro tells you that patients are hungry for this kind of specific, practical guidance. The video covers a mix of drug interactions, food interactions, and lifestyle factors that can either worsen side effects or reduce the effectiveness of GLP-1 medications.

The framing is useful: these are not necessarily absolute contraindications (your doctor may decide some are fine for your specific situation), but they are things to be aware of and discuss with your prescriber. Dr. G walks through twelve items, ranging from well-established medical interactions to more practical lifestyle considerations that do not show up on a standard prescribing information sheet.

Alcohol tops the list, and for good reason. GLP-1 drugs slow gastric emptying, which means alcohol sits in your stomach longer and gets absorbed differently than it would normally. Many patients report that their alcohol tolerance drops significantly on these medications, sometimes dramatically. You might feel the effects of one drink the way you used to feel three. Beyond the tolerance change, alcohol combined with nausea from the medication can be a particularly unpleasant combination. And for patients using GLP-1 drugs for diabetes, alcohol can interact with blood sugar regulation in unpredictable ways.

The List: What Deserves Your Attention

Beyond alcohol, the video covers high-fat meals (which worsen nausea and slow an already-slowed digestive system), carbonated beverages (which can increase bloating and gas), NSAIDs like ibuprofen (which may increase GI irritation on top of already-stressed digestive tissue), and certain diabetes medications that increase hypoglycemia risk when combined with GLP-1 drugs, particularly sulfonylureas and insulin.

The oral medication absorption point is one that patients often miss entirely. Because GLP-1 drugs slow gastric emptying, any oral medication you take may be absorbed more slowly or erratically than usual. This matters most for medications with narrow therapeutic windows, meaning drugs where the effective dose is close to the toxic dose. Blood thinners, seizure medications, and some cardiac drugs fall into this category. Dr. G recommends telling every prescriber you see (more than the one who prescribed the GLP-1 drug) that you are on a medication that affects gastric emptying.

Excessive sugar and highly processed carbohydrates also make the list, not because they interact with the drug pharmacologically, but because they can trigger worse nausea and blood sugar swings in combination with the medication. The video frames this practically: your body is already processing food differently on these drugs, so giving it easier-to-digest, nutrient-dense food makes the whole system run more smoothly.

Caffeine gets a nuanced treatment. Dr. G does not say to avoid it entirely but notes that some patients find caffeine on an empty stomach (which is more common when appetite is suppressed) triggers or worsens nausea. Switching from coffee to tea, adding a small snack with your coffee, or reducing overall caffeine intake may help if nausea is a problem.

What the Video Gets Right

The practical focus is the biggest strength. Many of these items would not come up in a standard prescribing conversation, but they genuinely affect patient experience. The oral medication absorption point alone could prevent a serious adverse event for someone on a narrow-therapeutic-window drug. The alcohol guidance is important safety information that too few patients receive. And the dietary recommendations are tailored to the specific digestive changes caused by GLP-1 drugs rather than being generic healthy eating advice.

Dr. G also strikes the right tone: informative without being scary. He presents these as things to be aware of and manage, not as dire warnings that should make you rethink taking the medication. This balanced approach serves patients better than either dismissing interactions or amplifying them into panic.

What It Misses

The video does not quantify risks for most items on the list, which leaves patients guessing about how serious each interaction actually is. There is a big difference between "this might make your nausea a little worse" and "this could cause a dangerous drop in blood sugar." Some risk stratification would help patients prioritize which items to address first.

Herbal supplements and over-the-counter products are not covered in detail. Many GLP-1 patients take supplements like probiotics, fiber products, or herbal remedies that could theoretically interact with the drug or be affected by the altered gastric emptying. A brief mention of this category would prompt patients to bring their supplement list to their doctor.

Questions to Bring to Your Doctor

This video generates a practical to-do list for your next appointment:

Bring a complete list of every medication, supplement, and over-the-counter product you take and ask your doctor to review it for potential interactions with your GLP-1 drug.

Ask specifically about any medication you take that has a narrow therapeutic window. Your doctor may want to monitor levels more closely or adjust timing.

Ask about alcohol guidelines specific to your situation. If you currently drink, get a clear recommendation about whether to stop, reduce, or simply be more cautious.

Ask about timing. Should you take your other medications at a specific time relative to your GLP-1 injection or relative to meals? Timing adjustments can sometimes manage absorption issues without changing doses.

Who Should Watch This

Everyone on a GLP-1 medication or about to start one should watch this. The interaction information is practical, the lifestyle guidance is immediately applicable, and the oral medication absorption point is genuinely important safety information that could affect your care. Share this with anyone you know who is on these drugs, because the odds are good that at least a few items on the list will be relevant to their situation and new to them.

The alcohol interaction deserves more detailed attention than it typically gets because the effects can be genuinely dangerous, more than uncomfortable. With slowed gastric emptying, alcohol stays in your stomach longer before being absorbed, which can give a false sense that you are handling the alcohol well. Then, when it does absorb, it can hit much harder and faster than expected. Patients have reported blacking out after two drinks when they previously had a much higher tolerance. For anyone who drives, this delayed absorption pattern creates a particularly risky situation because you might feel sober when your blood alcohol level is actually climbing. The safest approach during GLP-1 treatment is to dramatically reduce alcohol intake and never drive after any amount of alcohol until you understand your new tolerance level.

The drug interaction concern extends to over-the-counter medications that patients might not think to mention to their doctor. Antacids, for example, can interact with the altered gastric environment. Sleep aids containing diphenhydramine (Benadryl) can add to the drowsiness some patients already experience on GLP-1 drugs. Decongestants containing pseudoephedrine can raise blood pressure in patients who may already be managing hypertension alongside their GLP-1 treatment. The general rule is to mention every single thing you take, including supplements, vitamins, and occasional use medications, to your prescriber so they can identify potential interactions you might not have considered.

Dr. G's video is a useful reminder that GLP-1 drugs do not exist in isolation within your body. They change your digestive physiology in ways that ripple outward to affect how you process food, beverages, medications, and supplements. Thinking of your GLP-1 medication as a systemic change rather than a targeted intervention helps you approach these interactions with the right level of attention. You do not need to be afraid of everything, but you do need to be thoughtful about what you put into a body whose digestive processing has been fundamentally altered by the medication.

One final practical note: if you are managing multiple medications alongside your GLP-1 drug, ask your pharmacist to do a full drug interaction review. Pharmacists are specifically trained in drug interactions and often catch potential issues that prescribers, who may be focused on their own specialty, might miss. This is especially important if you have multiple prescribers (which is common for patients managing weight alongside diabetes, hypertension, or other conditions) because no single doctor may have the full picture of everything you are taking.

The smoking and vaping question is another area that the video could have addressed. While there is no direct pharmacological interaction between GLP-1 drugs and nicotine, the relationship is worth knowing because some patients report that their nicotine cravings decrease on GLP-1 medications, possibly through the same reward-circuit mechanisms that reduce food cravings. This could create an opportunity to reduce or quit smoking during treatment, but abrupt nicotine cessation can also produce its own set of symptoms (irritability, increased appetite, mood changes) that may complicate the GLP-1 adjustment period. If you are a smoker considering quitting alongside starting a GLP-1 drug, coordinating both changes with your healthcare team is advisable rather than trying to manage both transitions simultaneously without guidance.

The broader message of this video extends beyond the specific twelve items on the list. It is about developing a mindset of intentional, informed decision-making about everything that goes into your body during GLP-1 treatment. Your digestive system is operating differently than it was before the medication, and that difference affects everything from how quickly medications are absorbed to how your body processes different types of food and beverages. Approaching each consumption decision with that awareness, not anxiety, but simple awareness, leads to better outcomes and a more comfortable treatment experience overall.

Drug Interaction Evidence From Clinical Studies

GLP-1 drug interactions are primarily driven by delayed gastric emptying, which changes how quickly other medications are absorbed. A 2022 pharmacokinetic study published in Clinical Pharmacology and Therapeutics tested semaglutide co-administration with common medications and found that levothyroxine absorption was delayed by approximately 30 minutes and peak plasma concentration was reduced by 33% when taken at the same time as semaglutide versus alone. Oral contraceptive absorption was also affected, with a 2023 FDA review noting that ethinyl estradiol exposure decreased by 12-20% in women on GLP-1 agonists, which could reduce contraceptive efficacy in some women. The SUSTAIN and STEP trial safety databases identified that patients on warfarin required more frequent INR monitoring during GLP-1 initiation, as delayed absorption altered the anticoagulant steady state. For patients taking metformin alongside GLP-1 drugs, a 2021 analysis in Diabetes Care showed the combination was safe and additive for glucose control, but GI side effects were 40% more frequent in the combination group during the first 8 weeks compared to either drug alone. The practical takeaway is that any medication with a narrow therapeutic window, including thyroid drugs, anticoagulants, and seizure medications, should be monitored more closely during GLP-1 initiation and dose changes.